SCHLAP1 and prostate carcinoma: Moreover, SChLAP1 expression has also been associated with metastasis (odds ratio [OR] 2.45, 95% CI 1.70–3.53; p-value < 0·0001) and cancer progression (hazard ratio = 1.99, p-value = 0.032) in prostate cancer patients [46].